Sentagliptin Phosphate

磷酸森格列汀

Report date: 2025/11/20 15:36:42
NME

Base Information

Drug NameSentagliptin Phosphate
Drug Alias Name磷酸盛格列汀CetagliptinCetagliptin Phosphate盛捷维CGT-8012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved Date2024/12/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCgenetech(Suzhou China) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCgenetech(Suzhou China) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A